688278 特宝生物
交易中 09-30 09:52:39
资讯
新帖
简况
特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案获临时股东会审议通过，9月29日股价下跌0.78%
证券之星 · 09-29 17:36
特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案获临时股东会审议通过，9月29日股价下跌0.78%
股市必读：特宝生物新发布《特宝生物：2026年第四次临时股东会法律意见书》
证券之星 · 09-29 02:38
股市必读：特宝生物新发布《特宝生物：2026年第四次临时股东会法律意见书》
【机构调研记录】博时基金调研特宝生物
证券之星 · 09-24
【机构调研记录】博时基金调研特宝生物
股市必读：特宝生物（688278）9月23日披露最新机构调研信息
证券之星 · 09-24
股市必读：特宝生物（688278）9月23日披露最新机构调研信息
特宝生物：中金公司、红杉资本等多家机构于9月22日调研我司
证券之星 · 09-24
特宝生物：中金公司、红杉资本等多家机构于9月22日调研我司
每周股票复盘：特宝生物（688278）CT201明年或有数据读出
证券之星 · 09-20
每周股票复盘：特宝生物（688278）CT201明年或有数据读出
股市必读：特宝生物新发布《特宝生物：关于召开2026年第四次临时股东会的通知》
证券之星 · 09-14
股市必读：特宝生物新发布《特宝生物：关于召开2026年第四次临时股东会的通知》
每周股票复盘：特宝生物（688278）将召开临时股东会审议关联交易
证券之星 · 09-13
每周股票复盘：特宝生物（688278）将召开临时股东会审议关联交易
特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案，9月11日股价下跌4.51%
证券之星 · 09-11
特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案，9月11日股价下跌4.51%
特宝生物（688278）披露将参加科创板2026年半年度创新药行业集体业绩说明会，9月8日股价下跌0.91%
证券之星 · 09-08
特宝生物（688278）披露将参加科创板2026年半年度创新药行业集体业绩说明会，9月8日股价下跌0.91%
每周股票复盘：特宝生物（688278）累计回购738万股耗资4.07亿元
证券之星 · 09-06
每周股票复盘：特宝生物（688278）累计回购738万股耗资4.07亿元
股市必读：特宝生物新发布《特宝生物：关于股份回购进展公告》
证券之星 · 09-03
股市必读：特宝生物新发布《特宝生物：关于股份回购进展公告》
特宝生物（688278）披露股份回购进展公告，9月1日股价上涨0.14%
证券之星 · 09-01
特宝生物（688278）披露股份回购进展公告，9月1日股价上涨0.14%
东海证券：给予特宝生物买入评级
证券之星 · 09-01
东海证券：给予特宝生物买入评级
每周股票复盘：特宝生物（688278）2026年中报营收增21.58%
证券之星 · 08-23
每周股票复盘：特宝生物（688278）2026年中报营收增21.58%
特宝生物（688278）2026年中报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 08-20
特宝生物（688278）2026年中报简析：营收净利润同比双双增长，应收账款上升
特宝生物(688278)6月30日股东户数1.06万户，较上期增加11.39%
证券之星 · 08-19
特宝生物(688278)6月30日股东户数1.06万户，较上期增加11.39%
8月19日特宝生物涨7.05%，中欧价值发现混合A基金重仓该股
证券之星 · 08-19
8月19日特宝生物涨7.05%，中欧价值发现混合A基金重仓该股
国金证券：给予特宝生物买入评级
证券之星 · 08-19
国金证券：给予特宝生物买入评级
特宝生物（688278）披露2026年半年度报告，8月18日股价上涨2.66%
证券之星 · 08-18
特宝生物（688278）披露2026年半年度报告，8月18日股价上涨2.66%
加载更多
公司概况
公司名称：
厦门特宝生物工程股份有限公司
所属行业：
医药制造业
上市日期：
2020-01-17
主营业务：
厦门特宝生物工程股份有限公司的主营业务是免疫和代谢领域创新药物研发、生产和销售。公司的主要产品是派格宾、益佩生、珮金、特尔立、特尔津、特尔康。派格宾于2025年10月获批成为全球首个以慢乙肝临床治愈为治疗终点的药物，是该领域重要基石药物。
发行价格：
8.24
{"stockData":{"symbol":"688278","market":"SH","secType":"STK","nameCN":"特宝生物","latestPrice":52.29,"timestamp":1790733159000,"preClose":51.2,"halted":0,"volume":623042,"delay":0,"changeRate":0.0213,"floatShares":408000000,"shares":408000000,"eps":2.6456,"marketStatus":"交易中","change":1.09,"latestTime":"09-30 09:52:39","open":51.08,"high":52.38,"low":51.04,"amount":32371500,"amplitude":0.0262,"askPrice":52.32,"askSize":10,"bidPrice":52.28,"bidSize":170,"shortable":0,"etf":0,"ttmEps":2.6456,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1790739000000},"marketStatusCode":2,"adr":0,"adjPreClose":51.2,"symbolType":"stock_kcb","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":56.32,"lowLimit":46.08,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":408189480,"isCdr":false,"pbRate":6.73,"roa":"--","peRate":19.764893,"roe":"13.22%","epsLYR":2.53,"committee":0.614035,"marketValue":21344000000,"turnoverRate":0.0015,"status":0,"floatMarketCap":21344000000},"requestUrl":"/m/hq/s/688278/","defaultTab":"news","newsList":[{"id":"2671188142","title":"特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案获临时股东会审议通过，9月29日股价下跌0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671188142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671188142?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:36","pubTimestamp":1790674576,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，特宝生物报收于51.2元，较前一交易日下跌0.78%，最新总市值为208.99亿元。该股当日开盘51.55元，最高52.2元，最低50.9元，成交额达9233.77万元，换手率为0.44%。近日，特宝生物发布《2026年第四次临时股东会决议公告》显示，公司于2026年9月28日召开2026年第四次临时股东会，审议通过《关于与关联人共同投资暨关联交易的议案》。出席股东所持表决权占公司总表决权的26.5543%，议案获普通决议通过，关联股东回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900029167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252152","title":"股市必读：特宝生物新发布《特宝生物：2026年第四次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252152","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671252152?lang=zh_cn&edition=full","pubTime":"2026-09-29 02:38","pubTimestamp":1790620690,"startTime":"0","endTime":"0","summary":"公司公告汇总：特宝生物于2026年9月28日召开第四次临时股东会，审议通过《关于与关联人共同投资暨关联交易的议案》，中小投资者表决同意占比达99.72%。公司公告汇总特宝生物：2026年第四次临时股东会法律意见书厦门市锦天城（深圳）律师事务所出具法律意见书，确认厦门特宝生物工程股份有限公司2026年第四次临时股东会的召集、召开程序，召集人及出席人员资格，表决程序与表决结果均符合《公司法》《公司章程》等相关规定，会议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900002397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669661432","title":"【机构调研记录】博时基金调研特宝生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2669661432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669661432?lang=zh_cn&edition=full","pubTime":"2026-09-24 08:01","pubTimestamp":1790208104,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月23日披露的机构调研信息，博时基金近期对1家上市公司进行了调研，相关名单如下：1）特宝生物 调研纪要：益佩生目前销售情况基本符合预期。研发费用与研发项目投入需求相关。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400007538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669493433","title":"股市必读：特宝生物（688278）9月23日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669493433?lang=zh_cn&edition=full","pubTime":"2026-09-24 02:30","pubTimestamp":1790188237,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，特宝生物报收于53.1元，上涨1.84%，换手率0.66%，成交量2.7万手，成交额1.43亿元。机构调研要点：公司乙肝管线CT201已进入I期临床并完成首例受试者给药；CT580国内II期临床正有序推进，并开展与派格宾的联合治疗探索。机构调研要点9月22日特定对象调研益佩生目前销售情况基本符合预期；该产品于2025年5月获批，2025年12月纳入国家医保目录，在疗效、安全性及使用便捷性方面具备差异化优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669438531","title":"特宝生物：中金公司、红杉资本等多家机构于9月22日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2669438531","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669438531?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:05","pubTimestamp":1790183120,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月23日特宝生物发布公告称中金公司、红杉资本、中信建投、申万宏源、万家基金、幸福人寿、国盛证券、嘉实基金、安信基金、博时基金、太朴生命科学投资、德福资本、青榕资产、苏州云阳投资于2026年9月22日调研我司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400001885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668906218","title":"每周股票复盘：特宝生物（688278）CT201明年或有数据读出","url":"https://stock-news.laohu8.com/highlight/detail?id=2668906218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668906218?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:26","pubTimestamp":1789838774,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘，特宝生物报收于51.5元，较上周的52.05元下跌1.06%。本周，特宝生物9月14日盘中最高价报52.44元。本周关注点来自机构调研要点：CT201已进入I期临床并完成首例给药，公司希望明年有相关数据读出。来自机构调研要点：益佩生2026年1月1日起全国执行医保，覆盖人群与用药可及性明显提升。目前派格宾已参与广东联盟集采、江西牵头的干扰素省际联盟集采，两大联盟覆盖全国大部分地区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638746","title":"股市必读：特宝生物新发布《特宝生物：关于召开2026年第四次临时股东会的通知》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638746?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:10","pubTimestamp":1789330218,"startTime":"0","endTime":"0","summary":"公司公告汇总特宝生物：关于召开2026年第四次临时股东会的通知厦门特宝生物工程股份有限公司将于2026年9月28日召开2026年第四次临时股东会，会议采取现场投票与网络投票相结合方式，股权登记日为2026年9月21日，登记时间截至2026年9月24日16时。本次关联交易已通过董事会及独立董事专门会议审议，尚需提交股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667277500","title":"每周股票复盘：特宝生物（688278）将召开临时股东会审议关联交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2667277500","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667277500?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:50","pubTimestamp":1789242618,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，特宝生物报收于52.05元，较上周的56.96元下跌8.62%。本周关注点来自公司公告汇总：特宝生物将于2026年9月28日召开第四次临时股东会，审议与关联人共同投资1亿元的议案。厦门特宝生物工程股份有限公司将于2026年9月28日召开2026年第四次临时股东会，会议采取现场投票与网络投票相结合方式，股权登记日为2026年9月21日，登记时间截至2026年9月24日16时。公司董事蓝柏林先生以自有资金出资20,000万元，构成关联交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666781855","title":"特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案，9月11日股价下跌4.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666781855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666781855?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:35","pubTimestamp":1789137318,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，特宝生物报收于52.05元，较前一交易日下跌4.51%，最新总市值为212.46亿元。该股当日开盘54.46元，最高54.46元，最低51.85元，成交额达1.61亿元，换手率为0.75%。本次会议将审议《关于与关联人共同投资暨关联交易的议案》，中小投资者将单独计票，关联股东需回避表决。网络投票通过上海证券交易所系统进行，现场会议地点位于厦门市海沧新阳工业区翁角路330号公司会议室。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665290233","title":"特宝生物（688278）披露将参加科创板2026年半年度创新药行业集体业绩说明会，9月8日股价下跌0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665290233","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665290233?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:58","pubTimestamp":1788861490,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，特宝生物报收于56.6元，较前一交易日下跌0.91%，最新总市值为231.04亿元。近日，特宝生物发布《关于参加科创板2026年半年度创新药行业集体业绩说明会的公告》。公告显示，厦门特宝生物工程股份有限公司将于2026年9月16日15:00-17:00参加由上海证券交易所主办的科创板2026年半年度创新药行业集体业绩说明会，通过上证路演中心网络互动方式与投资者就2026年半年度经营成果及财务状况进行交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","06978","BK1574","688278","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365437","title":"每周股票复盘：特宝生物（688278）累计回购738万股耗资4.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365437?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:10","pubTimestamp":1788631822,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，特宝生物报收于56.96元，较上周的58.4元下跌2.47%。本周，特宝生物8月31日盘中最高价报58.27元。本周关注点来自公司公告汇总：特宝生物累计回购股份7,381,464股，占公司总股本的1.81%，已支付资金总额406,518,325.38元。2026年8月回购68,100股，支付资金3,724,450.38元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843724","title":"股市必读：特宝生物新发布《特宝生物：关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843724","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664843724?lang=zh_cn&edition=full","pubTime":"2026-09-03 01:31","pubTimestamp":1788370270,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至2026年8月31日，特宝生物累计回购股份7,381,464股，占总股本1.81%，已支付资金总额4.065亿元。公司公告汇总特宝生物：关于股份回购进展公告厦门特宝生物工程股份有限公司于2026年5月11日召开董事会，审议通过以集中竞价交易方式回购股份的方案，回购期限为2026年5月12日至2027年5月11日，拟回购金额为30,000万元至50,000万元，用于员工持股计划或股权激励及转换公司可转债。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664437857","title":"特宝生物（688278）披露股份回购进展公告，9月1日股价上涨0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664437857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664437857?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:50","pubTimestamp":1788274219,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，特宝生物报收于56.78元，较前一交易日上涨0.14%，最新总市值为231.77亿元。该股当日开盘56.69元，最高57.08元，最低56.35元，成交额达1.31亿元，换手率为0.57%。近日，特宝生物发布《关于股份回购进展公告》。2026年8月回购68,100股，支付资金3,724,450.38元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664884838","title":"东海证券：给予特宝生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2664884838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664884838?lang=zh_cn&edition=full","pubTime":"2026-09-01 12:20","pubTimestamp":1788236453,"startTime":"0","endTime":"0","summary":"东海证券股份有限公司杜永宏近期对特宝生物进行研究并发布了研究报告《公司简评报告：核心产品放量，Q2业绩提速》，给予特宝生物买入评级。派格宾循证医学证据持续积累，临床治愈基石地位不断夯实。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家。本文数据来源于东海证券股份有限公司，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100019647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661821191","title":"每周股票复盘：特宝生物（688278）2026年中报营收增21.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661821191","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661821191?lang=zh_cn&edition=full","pubTime":"2026-08-23 01:54","pubTimestamp":1787421252,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，特宝生物报收于61.88元，较上周的60.8元上涨1.78%。本周，特宝生物8月20日盘中最高价报66.8元。股本股东变化截至2026年6月30日，特宝生物股东户数为1.06万户，较3月31日增加1080户，增幅11.39%。户均持股数量由4.3万股降至3.86万股，户均持股市值为210.18万元。业绩披露要点特宝生物2026年中报显示，上半年主营收入18.37亿元，同比增长21.58%；归母净利润4.77亿元，同比增长11.37%；扣非净利润4.88亿元，同比增长13.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660476519","title":"特宝生物（688278）2026年中报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476519","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660476519?lang=zh_cn&edition=full","pubTime":"2026-08-20 06:03","pubTimestamp":1787177030,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期特宝生物发布2026年中报。截至本报告期末，公司营业总收入18.37亿元，同比上升21.58%，归母净利润4.77亿元，同比上升11.37%。按单季度数据看，第二季度营业总收入10.39亿元，同比上升24.07%，第二季度归母净利润3.12亿元，同比上升26.96%。本报告期特宝生物应收账款上升，应收账款同比增幅达77.65%。财务费用变动幅度为149.56%,原因:公司利息费用同比有所增加。本文数据来源于特宝生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000004770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660441277","title":"特宝生物(688278)6月30日股东户数1.06万户，较上期增加11.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660441277","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660441277?lang=zh_cn&edition=full","pubTime":"2026-08-19 18:02","pubTimestamp":1787133747,"startTime":"0","endTime":"0","summary":"证券之星消息，近日特宝生物披露，截至2026年6月30日公司股东户数为1.06万户，较3月31日增加1080.0户，增幅为11.39%。在生物制品行业个股中，特宝生物股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.53万户。从股价来看，2026年3月31日至2026年6月30日，特宝生物区间跌幅为15.12%，在此期间股东户数增加1080.0户，增幅为11.39%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900031506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660544680","title":"8月19日特宝生物涨7.05%，中欧价值发现混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660544680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660544680?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:44","pubTimestamp":1787129077,"startTime":"0","endTime":"0","summary":"证券之星消息，8月19日特宝生物涨7.05%创60日新高，收盘报64.4元，换手率3.11%，成交量12.69万手，成交额8.2亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为中欧基金的中欧价值发现混合A。中欧价值发现混合A目前规模为18.45亿元，最新净值3.3336，较上一交易日上涨0.06%，近一年上涨26.56%。中欧价值发现混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900028394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","166005","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411269","title":"国金证券：给予特宝生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660411269?lang=zh_cn&edition=full","pubTime":"2026-08-19 12:12","pubTimestamp":1787112733,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,马居东近期对特宝生物进行研究并发布了研究报告《益佩生商业化提速，二季度利润实现高增长》，给予特宝生物买入评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。本文数据来源于国金证券股份有限公司，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900018198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660498725","title":"特宝生物（688278）披露2026年半年度报告，8月18日股价上涨2.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660498725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660498725?lang=zh_cn&edition=full","pubTime":"2026-08-18 22:12","pubTimestamp":1787062345,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，特宝生物报收于60.16元，较前一交易日上涨2.66%，最新总市值为245.57亿元。近日，厦门特宝生物工程股份有限公司披露2026年半年度报告。本报告期实现营业收入1,836,563,644.13元，同比增长21.58%；利润总额529,487,419.62元，同比增长11.17%；归属于上市公司股东的净利润476,526,946.01元，同比增长11.37%；扣除非经常性损益后的净利润为488,115,653.17元，同比增长13.16%。经营活动产生的现金流量净额为336,543,862.34元，同比减少6.66%。研发投入占营业收入的比例为11.64%，较上年同期减少1.75个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800042364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790733161068,"stockEarnings":[{"period":"1week","weight":-0.018},{"period":"1month","weight":-0.1233},{"period":"3month","weight":-0.108},{"period":"6month","weight":-0.2203},{"period":"1year","weight":-0.382},{"period":"ytd","weight":-0.3813}],"compareEarnings":[{"period":"1week","weight":-0.0308},{"period":"1month","weight":-0.0308},{"period":"3month","weight":-0.0686},{"period":"6month","weight":-0.0227},{"period":"1year","weight":-0.0083},{"period":"ytd","weight":-0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"厦门特宝生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"10565人(较上一季度增加11.39%)","perCapita":"38636股","listingDate":"2020-01-17","address":"福建省厦门市海沧区新阳工业区翁角路330号","registeredCapital":"40818万元","survey":" 厦门特宝生物工程股份有限公司的主营业务是免疫和代谢领域创新药物研发、生产和销售。公司的主要产品是派格宾、益佩生、珮金、特尔立、特尔津、特尔康。派格宾于2025年10月获批成为全球首个以慢乙肝临床治愈为治疗终点的药物，是该领域重要基石药物。","listedPrice":8.24},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特宝生物,688278,特宝生物股票,特宝生物股票老虎,特宝生物股票老虎国际,特宝生物行情,特宝生物股票行情,特宝生物股价,特宝生物股市,特宝生物股票价格,特宝生物股票交易,特宝生物股票购买,特宝生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}